Blood & Cancer

Biosimilars with Dr. Gary Lyman

27 May 2021

Contributed by Lukas

Existing biosimilars are safe, effective alternatives to their reference biologics, and are increasingly being incorporated into oncology treatment gu...

Advanced bladder cancer: Dr. Arjun Balar talks treatment strategies in a changing field

20 May 2021

Contributed by Lukas

Systemic treatment for advanced urothelial cancer is quickly evolving. On this week's podcast, Arjun Balar, MD, director of the genitourinary medical ...

Gene therapies in hemophilia with Dr. Glenn Pierce

13 May 2021

Contributed by Lukas

A "very basic" type of gene therapy could potentially cure hemophilia, but a major hurdle has been the lack of an effective mode of delivery. Recent s...

Thrombosis and thrombocytopenia caused by COVID-19 vaccines: How to identify and treat VITT, VIPIT, or TTS

06 May 2021

Contributed by Lukas

At least 17 cases of thrombosis and thrombocytopenia have been reported in patients who received the Johnson & Johnson COVID-19 vaccine in the United ...

Toward more personalized treatment in prostate cancer: The CCR score predicts metastasis and guides treatment decisions after radiation

29 Apr 2021

Contributed by Lukas

The combined clinical cell-cycle risk (CCR) score uses clinical and genetic factors to assess the risk of metastasis after radiation therapy in patien...

Changing perspectives: Dr. Michael Weiner recounts his experiences as an oncologist who became a cancer patient and then a caregiver

22 Apr 2021

Contributed by Lukas

Pediatric oncologists are used to dealing with emotional, heart-wrenching situations, but oncology took on a new dimension for Michael Weiner, MD, whe...

Optimizing CAR T-cell therapies in lymphoma: Improving response, fighting cytokine release syndrome, and identifying mechanisms of resistance

15 Apr 2021

Contributed by Lukas

Studies have shown that chimeric antigen receptor (CAR) T-cell therapies produce responses in patients with relapsed/refractory B-cell lymphomas, but ...

Trends in genetic testing for breast and ovarian cancer: Undertesting and racial/ethnic disparities persist

08 Apr 2021

Contributed by Lukas

Researchers have tracked the evolution of genetic germline testing in women with breast or ovarian cancer in recent years and reported the results in ...

Improving cancer screening in the COVID era: Drive By Flu-FIT allows for socially distanced colorectal cancer screening

01 Apr 2021

Contributed by Lukas

A program called Drive By Flu-FIT has allowed for socially distanced colorectal cancer (CRC) screening during the COVID-19 pandemic. Armenta Washingto...

Unpacking von Willebrand disease guidelines: Dr. Paula James talks diagnosis and pre-procedure prophylaxis

25 Mar 2021

Contributed by Lukas

Earlier this year, clinical practice guidelines for the diagnosis and management of von Willebrand disease (VWD) were published in Blood Advances. The...

FDA approvals in hematology and oncology, Part II: New oral formulations, RET and MET inhibitors, and CAR T-cell therapies

18 Mar 2021

Contributed by Lukas

We continue our review of drugs recently approved by the Food and Drug Administration (FDA) in the hematology/oncology space. In part 1 of our review...

How I treat CLL and MCL: From 'watch and wait' to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant

11 Mar 2021

Contributed by Lukas

Treatments for chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) have advanced in recent years, with more new developments on the hori...

COVID-19 vaccination in cancer patients: Who should be vaccinated and when?

04 Mar 2021

Contributed by Lukas

When should cancer patients receive a COVID-19 vaccine? The National Comprehensive Cancer Network (NCCN) has issued recommendations to provide guidanc...

Managing pain in sickle cell crisis with Dr. Ifeyinwa Osunkwo

25 Feb 2021

Contributed by Lukas

Ifeyinwa (Ify) Osunkwo, MD, MPH, joins us to talk about her approach to pain management in patients suffering from sickle cell crisis as well as the c...

FDA approvals in hematology and oncology: Novel agents and new tricks for old drugs

18 Feb 2021

Contributed by Lukas

In this episode, we review drugs recently approved by the Food and Drug Administration in the hematology/oncology space. David M. Mintzer, MD, of Penn...

NCI-MATCH trial reveals actionable mutations and matches cancer patients to targeted therapies

11 Feb 2021

Contributed by Lukas

The NCI-MATCH trial was designed to reveal mutations in underexplored cancer types, allowing researchers to match patients to appropriate targeted the...

COVID-19 vaccine 101: Dr. Drew Weissman discusses mechanisms, efficacy, and vaccinating patients with cancer or HIV

04 Feb 2021

Contributed by Lukas

How do the various COVID-19 vaccines work, and when should patients be vaccinated? We tackle these topics and more in this episode. Our host David H....

Barriers to clinical trial enrollment for patients with gynecologic cancers: Why patients don't participate and how to improve enrollment

28 Jan 2021

Contributed by Lukas

The greatest barrier to clinical trial enrollment is patients not knowing an appropriate trial exists, according to a survey of gynecologic cancer sur...

Convalescent plasma for COVID-19, race linked to cancer-associated thrombosis risk, iron deficiency common in pregnancy, and more from 'Best of ASH'

21 Jan 2021

Contributed by Lukas

New studies have shed additional light on how convalescent plasma may affect patients with COVID-19, how blood type impacts bleeding risk, the effects...

Thrombosis research from ASH 2020: Khorana score falls short in cancer study, factors predict VTE in cancer patients with COVID-19, and antithrombotics don't affect severe COVID outcomes

14 Jan 2021

Contributed by Lukas

Three studies revealed new findings on thrombosis in patients with cancer and/or COVID-19. These studies were presented at the 2020 annual meeting of ...

Highlights from SABCS 2020: New data on CDK4/6 inhibitors, omitting chemotherapy and radiotherapy, underreporting toxicity, and predicting outcomes in breast cancer

07 Jan 2021

Contributed by Lukas

A number of groundbreaking and practice-changing studies were presented at the San Antonio Breast Cancer Symposium 2020. The RxPONDER, ADAPT, and PRIM...

Best of Blood & Cancer 2020

24 Dec 2020

Contributed by Lukas

In this episode, we bring you clips from the best Blood & Cancer shows of 2020. Blood & Cancer will be back with new episodes in 2021.  ESMO 2020: ...

SABCS 2020: More women may forgo chemo, surgery's role in opioid use, and pregnancy after breast cancer

22 Dec 2020

Contributed by Lukas

News from SABCS 2020: RxPONDER: Even more women may forgo chemo for breast cancer: https://bit.ly/2LIYjZt Breast surgery may be a gateway to addictiv...

How does COVID-19 affect patients with hematologic malignancies? The ASH registry provides some answers

17 Dec 2020

Contributed by Lukas

The ASH Research Collaborative COVID-19 Registry for Hematology was established earlier this year to study patients with hematologic malignancies diag...

News from ASH 2020: 'Practice-changing' results with ruxolitinib in chronic GVHD and no benefit seen with tranexamic acid in patients with blood cancers and severe thrombocytopenia

15 Dec 2020

Contributed by Lukas

News from ASH 2020: No benefit from tranexamic acid prophylaxis in blood cancers: https://bit.ly/2K3Mah1 'Practice changing': Ruxolitinib as second-l...

How I treat GVHD: Dr. James Ferrara explains how biomarkers can predict outcomes and guide the treatment of acute GVHD

10 Dec 2020

Contributed by Lukas

A pair of biomarkers are being used to guide treatment and predict mortality in patients with graft-versus-host disease (GVHD), according to James L.M...

Black patients with ES-SCLC get less chemo, CTCs may guide breast cancer treatment, and new FDA approvals for neuroblastoma and prostate cancer

08 Dec 2020

Contributed by Lukas

Blood & Cancer news stories: Black patients with ES-SCLC get less chemo but have better survival: https://bit.ly/33Rb5eB Should CTCs guide treatmen...

Can aerosolized chemotherapy better treat peritoneal carcinomatosis in patients with gynecologic or gastrointestinal cancers?

03 Dec 2020

Contributed by Lukas

Researchers are conducting the first U.S. trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) for the treatment of peritoneal carcin...

News | Checkpoint inhibitors and COVID-19 mortality; HCC rates slow in cities, continue to climb in rural areas

01 Dec 2020

Contributed by Lukas

Blood & Cancer News Stories:  Immune checkpoint inhibitors don't increase COVID-19 incidence or mortality, studies suggest: https://bit.ly/2JlP2FN H...

Journal highlights with Dr. David Henry: Managing hematologic conditions in pregnancy, combo for elderly AML, genomics in DLBCL, and COVID-19 updates

26 Nov 2020

Contributed by Lukas

In this episode, host David H. Henry, MD, highlights some recent articles from Blood, the Journal of Clinical Oncology, and the New England Journal of...

Cancer and hepatitis B virus: ASCO's recommendations for HBV screening, monitoring for reactivation, and how to treat patients

19 Nov 2020

Contributed by Lukas

In this episode, we discuss updated guidelines on the screening and management of hepatitis B virus (HBV) in patients about to start anticancer therap...

How to kill a trial

17 Nov 2020

Contributed by Lukas

The Tomosynthesis Mammography Imaging Screening Trial (TMIST) was designed to see if 3-D mammography, or tomosynthesis, could help personalize screeni...

Post-HSCT care at home: Can maintaining the patient's microbiome prevent GVHD, improve other outcomes, decrease costs, and reduce the risk of COVID-19?

12 Nov 2020

Contributed by Lukas

Can receiving all posttransplant care at home benefit patients undergoing hematopoietic stem cell transplant (HSCT)? Researchers are conducting phase ...

Real-world checkpoint inhibitor results not as good as trial results

10 Nov 2020

Contributed by Lukas

Hematology Oncology News:  IMRT new standard of care for high-risk cervical cancer: https://bit.ly/3k7ji3y Real-world results with checkpoint inhibi...

How I treat NSCLC in the era of checkpoint inhibitors and the COVID-19 pandemic

05 Nov 2020

Contributed by Lukas

In this episode, we review how immune checkpoint inhibitors and COVID-19 have changed the management of non-small cell lung cancer (NSCLC). Jeffrey C...

Breast cancer risk with HRT, statins and colorectal cancer, and SBRT for lung metastases

03 Nov 2020

Contributed by Lukas

News from MDedge Hematology-Oncology: New estimates for breast cancer risk with HRT: https://bit.ly/37VT0Pt BMJ study: https://bit.ly/2TKDIVt Lancet ...

How to use antiemetics: Dr. Paul Hesketh reviews ASCO's guidelines on antiemetic use in cancer patients receiving checkpoint inhibitors or antineoplastic agents

29 Oct 2020

Contributed by Lukas

In this episode, we review the latest guidelines on antiemetics from the American Society of Clinical Oncology (ASCO). Host David H. Henry, MD, is jo...

Patients will gain access to clinical notes, lung cancer screening guidelines fall short, and AML standard remains elusive

27 Oct 2020

Contributed by Lukas

Hematology-Oncology News:  National lung cancer screening guidelines may miss younger African American individuals at high risk: https://bit.ly/3e2C...

Hematology case review: Suspected ITP, presumed heparin-induced thrombocytopenia, and an 'interesting' case of anemia

22 Oct 2020

Contributed by Lukas

In this episode, we review three hematology cases. One case illustrates the work-up and treatment of immune thrombocytopenia (ITP). Another case demon...

Choosing surgery for older breast cancer patients, delayed screening from COVID-19 could increase deaths, and blood group O linked to decreased SARS-CoV-2 risk

20 Oct 2020

Contributed by Lukas

Hematology Oncology News: Study advances personalized treatment for older breast cancer patients (https://bit.ly/3dHieSk) Delayed cancer screening c...

TERAVOLT registry sheds light on characteristics, treatment, and outcomes of patients with thoracic cancers and COVID-19

15 Oct 2020

Contributed by Lukas

How do patients with thoracic cancers fare when they develop COVID-19? The researchers behind the TERAVOLT registry are trying to find out. TERAVOLT i...

FDA approves combo immunotherapy for mesothelioma, atezolizumab strikes out in ovarian cancer, and more

13 Oct 2020

Contributed by Lukas

Hematology-Oncology News:  Radiotherapy planning scans reveal breast cancer patients' CVD risk (https://bit.ly/2FeoJiH) FDA OKs combination immunot...

The psychiatry of cancer, a crossover from the Psychcast

08 Oct 2020

Contributed by Lukas

Lorenzo Norris, MD, host of Psychcast, joins Blood & Cancer host David Henry, MD, to discuss steps clinicians can take to alleviate the distress assoc...

Global stomach cancer deaths decline but colorectal cancer deaths stagnate; plus, divergent results for paclitaxel/nab-paclitaxel for triple negative breast cancer

06 Oct 2020

Contributed by Lukas

Hematology-Oncology News:  Divergent findings with paclitaxel and nab-paclitaxel in TNBC (https://bit.ly/33vemjS) Palbociclib plus letrozole improve...

ESMO 2020: Late-breaking and practice-changing studies on COVID-19 and breast, lung, gastrointestinal, and other cancers

01 Oct 2020

Contributed by Lukas

There were a number of practice-changing and ground-breaking studies presented at the ESMO 2020 Virtual Congress, according to our guest in this episo...

Hem-Onc News: No benefit from postop radiotherapy in NSCLC, sotorasib is a 'triumph of drug discovery,' and choosing a TKI for ALL

29 Sep 2020

Contributed by Lukas

Hematology-Oncology News: No benefit with postoperative radiotherapy in stage IIIA2 NSCLC (https://bit.ly/3i1196r) First-in-class ADC ups survival in...

Studying cancer patients with COVID-19: Dr. Brian Rini describes the NCCAPS and CCC19 studies and reviews the latest findings

24 Sep 2020

Contributed by Lukas

How do patients fare when they have cancer and COVID-19? Researchers developed the COVID-19 and Cancer Consortium (CCC19) and the National Cancer Inst...

Waist size and prostate cancer death, AI is on par with radiologists for mammograms, and "How I Treat" MDS from ASH Hematologic Malignancies

22 Sep 2020

Contributed by Lukas

This week in Hematology and Oncology news: Large waistline linked to higher risk of prostate cancer death (https://bit.ly/3iRxmya) FOLFOXRI tops doub...

Medical school in the COVID era: Two RCSI students explain how the pandemic has affected them

17 Sep 2020

Contributed by Lukas

How has COVID-19 impacted medical students? Two students from Royal College of Surgeons in Ireland (RCSI), Dublin, describe their experiences in this ...

Gene testing for all breast cancer patients with second primary malignancy, atezolizumab for TNBC, pralsetinib for NSCLC, and more

15 Sep 2020

Contributed by Lukas

Hematology/Oncology News: Study supports multigene panel testing for all breast cancer patients with second primary cancers: https://bit.ly/3m6RyOGS...

How I treat MDS: Dr. Shannon McCurdy talks prognostic scoring, ESAs, HMAs, transplant, and more

10 Sep 2020

Contributed by Lukas

Treatment strategies for myelodysplastic syndromes (MDS) vary widely depending upon patients' prognosis. In this episode, Shannon R. McCurdy, MD, of t...

Hem-Onc News: Delaying radiotherapy for high-risk prostate cancer; melanoma experts say 'no' to routine gene profile testing

08 Sep 2020

Contributed by Lukas

Blood & Cancer News:   Delaying RT for higher-risk prostate cancer found safe: https://bit.ly/2F1cKoQ Source: https://bit.ly/2FaaMCr RTOG 9413: http...

Best of the 2020 American Society of Clinical Oncology Annual Meeting

03 Sep 2020

Contributed by Lukas

Episode 94 features the best of ASCO 2020, and we'll see you all with new content for episodes 95 and 96.  *  *  * Best of: How did it go? Nick An...

Hem-Onc News: Aspirin linked to cancer progression in older adults, inhibitor could 'alter landscape' of RET+ tumors, and Black-White gap closing

01 Sep 2020

Contributed by Lukas

MDedge Hematology-Oncology news for the first week of September 2020.  Aspirin may accelerate cancer progression in older adults: https://bit.ly/2EN...

SECURE-SCD: A registry of patients with sickle cell disease and COVID-19

27 Aug 2020

Contributed by Lukas

The SECURE-SCD registry was designed to collect and disseminate information on patients with sickle cell disease (SCD) who develop COVID-19. Two of th...

Diabetes + weight loss could mean a higher risk of pancreatic cancer, digital breast tomosynthesis vs digital mammography, and adjuvant chemo is beneficial for some with low-grade glioma

25 Aug 2020

Contributed by Lukas

News for the week of August 24, 2020.  Beyond baseline, DBT no better than mammography for dense breasts: https://bit.ly/2FTRnpp Study source: https...

Mason Plumlee: NBA star in the Orlando bubble, medical entrepreneur, and COVID-19 survivor

20 Aug 2020

Contributed by Lukas

Dr. David Henry welcomes NBA power forward Mason Plumlee. Plumlee, who is now participating in the NBA's controlled COVID-19 environment, affectionate...

Hem Onc News: Chemo-free treatment of mesothelioma, FDA approves liquid biopsy for NSCLC, and swallowable device for esophageal cancer

18 Aug 2020

Contributed by Lukas

Hematology-Oncology news: Chemo-free management of mesothelioma on horizon: https://bit.ly/2CyL6xY CheckMate 743: https://bit.ly/2CBy6HX INITIATE tri...

ISTH 2020: Dr. Hanny Al-Samkari talks VTE in COVID-19, bevacizumab in HHT, and predisposition to thrombosis in NSCLC

13 Aug 2020

Contributed by Lukas

Hanny Al-Samkari, MD, joins the podcast to discuss thrombosis in COVID-19 and lung cancer patients as well as the use of bevacizumab in patients with ...

Immunotherapy doesn't impact COVID mortality, breast cancer screening for the developing world, and 2 FDA approvals

11 Aug 2020

Contributed by Lukas

Subscribe to Blood & Cancer: Apple Podcasts, Spotify, Google Podcasts This week in HemOnc news: Study: Immune checkpoint inhibitors don't increase...

How I treat multiple myeloma: Dr. Gustavo Fonseca talks triple-agent therapy, transplant, and treatment failure

06 Aug 2020

Contributed by Lukas

How does the community oncologist treat multiple myeloma? Gustavo A. Fonseca, MD, of Florida Cancer Specialists, shares his approach to myeloma treatm...

News from EAU20, ISTH, and AACR's COVID-19 & Cancer meeting: Surgery in renal cell cancer, bevacizumab in HHT, and nosocomial COVID-19

04 Aug 2020

Contributed by Lukas

Subscribe to Blood & Cancer: Apple Podcasts, Spotify, Google Podcasts   This week in HemOnc News: Higher death rate seen in cancer patients with n...

Beyond the lungs: How COVID-19 affects the blood, brain, gastrointestinal system, and other organ systems

30 Jul 2020

Contributed by Lukas

COVID-19 can have a negative impact on systems throughout the body, beyond just the lungs, according to a review published in Nature Medicine. Two aut...

RTL 03 - HemOnc News: New 'gold standard' for prostate cancer screening, pandemic could increase cancer deaths, genetic testing for early cancers

28 Jul 2020

Contributed by Lukas

Subscribe to Blood & Cancer: Apple Podcasts, Spotify, Google Podcasts This week in HemOnc News: PSMA PET/CT may be new 'gold standard' for prostate c...

Hematology|Oncology Journal Club 01 - All about breast cancer: Lumpectomy margins, partial vs whole breast irradiation, locoregional management after neoadjuvant chemo

23 Jul 2020

Contributed by Lukas

While relaxing on the Jersey Shore, host and MDedge Hematology/Oncology Editor-in-Chief, David Henry, MD, dove into the July 10, 2020, issue of the J...

RTL 02 -- The latest news from MDedge Hematology/Oncology: MRI IDs significant prostate cancer, drug interactions to avoid in GI cancers, ctDNA clearance tracks with NSCLC survival, COVID symptoms persist

21 Jul 2020

Contributed by Lukas

The latest news from MDedge Hematology/Oncology:  In this episode:  MRI reliably identifies significant prostate cancer * Original MDedge article (...

Cancer and diet: Dr. Dawn Lemanne describes how fasting can suppress the immune system and lower IGF-1 and blood sugar levels

16 Jul 2020

Contributed by Lukas

Cancer patients often ask what they should eat, but it's just as important to know when they should eat, according to Dawn Lemanne, MD, of Oregon Inte...

Introducing Run the List: the latest hem onc news - Earlier lung screening doubles eligibility, lifestyle reduces breast cancer risk regardless of genetics, FDA approves MDS/CMML drug, COVID mask exemptions

14 Jul 2020

Contributed by Lukas

The latest news for hematology and oncology professionals. In this episode:  USPSTF: Earlier lung cancer screening can double eligibility * Review...

Personal and professional impact of COVID-19 - diary of an oncologist and vacation on the shore

09 Jul 2020

Contributed by Lukas

Oncologist Don S. Dizon, MD, joins the podcast to discuss how the COVID-19 pandemic has affected him personally and professionally. Dr. Dizon is the d...

Patient anxiety, social support, optimism bias, and 'How long do I have left?': The best-of Dr. Ilana Yurkiewicz

02 Jul 2020

Contributed by Lukas

Ilana Yurkiewicz, MD, recorded dozens of Clinical Correlation segments for Blood & Cancer for more than a year. She also hosted a three-part series o...

EHA25: AML, myeloma, polycythemia vera, and COVID-19 with EHA President John Gribben

25 Jun 2020

Contributed by Lukas

EHA25 highlights: EHA President John Gribben talks AML, myeloma, polycythemia vera, and COVID-19 What were the late-breaking and practice-changing pre...

Drugs FDA-approved for hematology / oncology in 2020: 'Game-changing' and 'niche' indications

18 Jun 2020

Contributed by Lukas

The Food and Drug Administration has approved dozens of drugs for new hematology/oncology indications this year. Host David Henry, MD, was joined by D...

ASCO 2020: Practice-changing studies in breast, lung, colorectal, and other cancers

11 Jun 2020

Contributed by Lukas

What were the practice-changing studies presented at the 2020 ASCO Annual Meeting? Podcast host David H. Henry, MD, and retired oncologist Alan P. Lys...

Non–small cell lung cancer: How to choose the best therapy and reviewing the first virtual ASCO

04 Jun 2020

Contributed by Lukas

Jack West, MD, joins the podcast to discuss how he chooses first-line treatment in new patients with non–small cell lung cancer (NSCLC). Dr. West is...

Would you choose oncology again? Plus, breast cancer research: HER2CLIMB, KEYNOTE 522, and DESTINY BREAST01 with Dr. Bill Gradishar

28 May 2020

Contributed by Lukas

David H. Henry, MD, answers the question, "Would you choose oncology again?" This question was asked of oncologists surveyed for the Medscape Oncolog...

VTE rate, 'COVID toes,' and Virchow's triad: What you need to know about COVID and coagulation

21 May 2020

Contributed by Lukas

Adam C. Cuker, MD, joins host David H. Henry, MD, to discuss recent findings regarding coagulation in COVID-19 patients. Both Dr. Cuker and Dr. Henry ...

Curbsiders Host Dr. Matt Watto on being an internist in the COVID-19 pandemic

14 May 2020

Contributed by Lukas

In this episode, Matthew Watto, MD, an internist at Pennsylvania Hospital in Philadelphia, tells host David H. Henry, MD, also of Pennsylvania Hospita...

Treating genitourinary malignancies in the COVID-19 era

07 May 2020

Contributed by Lukas

How should oncologists be treating genitourinary malignancies during the COVID-19 pandemic? Aly-Khan A. Lalani, MD, of McMaster University in Hamilton...

The first virtual ASCO meeting; plus Part 2 of tech tools for docs

30 Apr 2020

Contributed by Lukas

The American Society of Clinical Oncology is gearing up for its first-ever virtual meeting at the end of May 2020. ASCO's president Howard A. "Skip" B...

Treating colorectal cancer in the COVID-19 era

23 Apr 2020

Contributed by Lukas

Oncologists are now weighing the benefits of treating cancer patients against the risk of exposing them to SARS-CoV-2. David Kerr, MD, DSc, of Univers...

COVID-19 and the community oncologist

16 Apr 2020

Contributed by Lukas

How are community oncologists adapting to the COVID-19 pandemic? Podcast host David H. Henry, MD, of Pennsylvania Hospital in Philadelphia, explores t...

COVID-19 and lung cancer: The decision to delay treatment

09 Apr 2020

Contributed by Lukas

In the "new normal" of treating cancer patients during COVID-19, when do you decide to start treatment or pause it? Narjust Duma, MD, a thoracic oncol...

Bonus: COVID-19 critical-care lessons from Seattle

07 Apr 2020

Contributed by Lukas

As the nation's health care system braces for COVID-19 cases, physicians who've faced the pandemic first have critical lessons for everyone. In this b...

COVID-19: 'The world has changed'

02 Apr 2020

Contributed by Lukas

Zainab Shahid, MD, medical director of bone marrow transplant infectious diseases at the Levine Cancer Institute/Atrium Health in Charlotte, N.C., bre...

Grands rounds in the age of COVID-19; cardiotoxicity in breast cancer

26 Mar 2020

Contributed by Lukas

Susan Dent, MD, codirector of the cardio-oncology program at Duke University in Durham, N.C., reflects on virtual grand rounds, telehealth, the screen...

Tech tools for docs: Apps, sites, and software in the virtual world

19 Mar 2020

Contributed by Lukas

David Henry, MD, welcomes Bernard A. Mason, MD, to discuss Dr. Mason's favorite digital tools for working as a physician in part 1 of 2. Dr. Mason is ...

Common bleeding and coagulation issues

12 Mar 2020

Contributed by Lukas

There's an art to taking a thorough bleeding history. In this episode, Adam Cuker, MD, director of the Hemophilia and Thrombosis Center at the Univers...

Is this a good study? The statistics tell the story

05 Mar 2020

Contributed by Lukas

Ever read through a study and wondered how to apply the hazard ratio, or if you should change your practice because of a secondary endpoint finding? I...

Treatment approaches in AML

27 Feb 2020

Contributed by Lukas

A diagnosis of acute myeloid leukemia (AML) was once an emergency, requiring immediate treatment. Today, the need to start treatment is still urgent, ...

Treatment tips in CLL

20 Feb 2020

Contributed by Lukas

The million-dollar question in the treatment of chronic lymphocytic leukemia (CLL) is what to do after a patient relapses following treatment with ven...

When to refer for CAR T-cell therapy

13 Feb 2020

Contributed by Lukas

Chimeric antigen receptor (CAR) T-cell therapy is one of the hottest advances in lymphoma treatment, but who should get it and what does the process l...

Understanding biosimilars

06 Feb 2020

Contributed by Lukas

Think of biosimilars as your mother's minestrone soup: It's the same recipe and ingredients every time, but not every batch is chemically identical, e...

ASH19 special report

30 Jan 2020

Contributed by Lukas

Blood & Cancer takes you behind the podium at the American Society of Hematology annual meeting for an in-depth look at the latest developments in ane...

Sickle cell update: Treating pain and progress toward cure

23 Jan 2020

Contributed by Lukas

When it comes to treating pain related to sickle cell disease, consider the underlying factors, from constipation to compression spine deformity. That...

Practice-changing research in GI cancer

16 Jan 2020

Contributed by Lukas

Daniel G. Haller, MD, of the University of Pennsylvania, Philadelphia, joins Blood & Cancer host David H. Henry, MD, also of the University of Pennsyl...

Palliative care: Not just another word for hospice

09 Jan 2020

Contributed by Lukas

Thomas LeBlanc, MD, of Duke Cancer Institute in Durham, N.C., joins host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, to discuss the ev...

The best of Clinical Correlation

02 Jan 2020

Contributed by Lukas

In this special edition podcast, we bring you the best of Clinical Correlation, a segment on the human side of hematology-oncology care. Clinical Corr...

ICYMI: Get to know Dr. Ilana Yurkiewicz

26 Dec 2019

Contributed by Lukas

In this special edition podcast, Blood & Cancer revisits an interview with Ilana Yurkiewicz, MD, of Stanford (Calif.) University. Dr. Yurkewicz is the...

ASCO president on uniting the oncology field

19 Dec 2019

Contributed by Lukas

Howard "Skip" Burris, MD, chief medical officer of Sarah Cannon Cancer Institute in Nashville, Tenn., joins the podcast to talk about what it's like t...

2019 drug approvals in hematology-oncology

12 Dec 2019

Contributed by Lukas

David Mintzer, MD, of the University of Pennsylvania, Philadelphia, joins the podcast to discuss noteworthy drug approvals in hematology-oncology in 2...